@article{0525316417ca4b339630129aec33e803,
title = "The critical need for alternative antiretroviral formulations, and obstacles to their development",
author = "Susan Swindells and Charles Flexner and Fletcher, {Courtney V.} and Jacobson, {Jeffrey M.}",
note = "Funding Information: Potential conflicts of interest: S. S. has received research grants or contracts from or has been a consultant for Abbott Pharmaceuticals, Bavarian Nordic, GlaxoSmithKline, Novartis Pharmaceuticals Corporation, Pfizer, and Tibotec Therapeutics. C. V. F. has served as an ad hoc consultant to Bristol-Myers Squibb and Merck, Inc, and received honorarium payments for such participation. C. F. has received grant support from GlaxoSmithKline for research unrelated to this manuscript; has served as a consultant to Bristol-Myers Squibb, Boehringer-Ingelheim, GlaxoSmithKline, Merck, Roche, Schering-Plough, and Tibotec; and has received honoraria for presentations at meetings sponsored in part by Abbott Laboratories. J. J. has received research grants from Progenics and Tanox (now Taimed). Funding Information: This work was supported by the AIDS Clinical Trials Group funded by the National Institute of Allergy and Infectious Diseases (grants U01 AI68636 and AI068634; AI69450 to S. S.; AI069465 to C. F.; and P01 AI074340, UOI AI68636, and UOI AI68632 to C. V. F.); and the National Institute of Drug Abuse (P01 DA028555-01A1 to S. S. and C. V. F.).",
year = "2011",
month = sep,
day = "1",
doi = "10.1093/infdis/jir370",
language = "English (US)",
volume = "204",
pages = "669--674",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "5",
}